
B/m/vinci8/data1/riedel/corpora/nyt/nyt/data/2006/01/12/1731320.xmlï

JANINENNPO

	CARPENTERNNPO

arrivedVBDO

atINO

ColumbiaNNPORGANIZATION


UniversityNNPORGANIZATION

inINO

	SeptemberNNPO

withINO


aDTO


complexionNNO

asRBO

clearJJO

asINO

herPRP$O

brightJJO

blueJJO

eyesNNSO
	
..OEÇÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f800000000000ecb3 *ORGANIZATION§

ButCCO

duringINO

herPRP$O

firstJJO

monthNNO

ofINO

collegeNNO
	
,,O

herPRP$O

faceNNO

beganVBDO

breakingVBGO

outRBO

inINO

pimplesNNSO

andCCO

deepJJO
	
,,O

inflamedJJO

nodulesNNSO
	
,,O

theDTO

sameJJO

symptomsNNSO

thatWDTO

hadVBDO

plaguedVBNO

herPRP$O

earlyRBO

inINO

highJJO

schoolNNO

inINO

SanNNPLOCATION

JoseNNPLOCATION
	
,,O

Calif.NNPLOCATION

''''O

MyPRP$O

acneNNO

justRBO

immediatelyRBO

startedVBDO

toTOO

comeVBO

backRBO

atINO


aDTO

reallyRBO

rapidJJO

rateNNO
	
,,O

''''O

Ms.NNPPERSON

	CarpenterNNPPERSON
	
,,O

18CDO
	
,,O

saidVBDO
	
..OÉÄÄÄ¯ˇˇˇˇ5 6*PERSONÑÄÄÄ¯ˇˇˇˇ$ $*LOCATIONAÖÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f800000000006809a! "*LOCATIONó

SoINO

herPRP$O

doctorNNO

gaveVBDO

herPRP$O

theDTO

potentJJO

acneJJO

drugNNO

isotretinoinNNO
	
,,O

bestRBO

knownVBNO

asINO

AccutaneNNPPERSON
	
..OÜÄÄÄ¯ˇˇˇˇ *PERSONÕ

TheDTO

prescriptionNNO

cameVBDO

withINO


aDTO

brightJJO

yellowJJO

labelNNO

assuringVBGO

theDTO


pharmacistNNO

thatINO

Ms.NNPPERSON

	CarpenterNNPPERSON

wasVBDO

notRBO

pregnantJJO
	
,,O

becauseINO

AccutaneNNPO

canMDO

causeVBO

severeJJO

birthNNO

defectsNNSO
	
..OáÄÄÄ¯ˇˇˇˇ *PERSON

ShePRPO

agreedVBDO

toTOO

alsoRBO

haveVBO


aDTO

	pregnancyNNO

testNNO

eachDTO

monthNNO

beforeINO

	refillingVBGO

herPRP$O

prescriptionNNO
	
,,O

evenRBO

thoughINO

shePRPO

takesVBZO

birthNNO

controlNNO

pillsNNSO
	
..OÜ

TheseDTO

precautionsNNSO

wereVBDO

partNNO

ofINO


aDTO

programNNO

	organizedVBNO

byINO

theDTO

makersNNSO

ofINO

AccutaneNNPO

andCCO

otherJJO

brandsNNSO

ofINO

isotretinoinNNO

-LRB--LRB-O

	AmnesteemNNPORGANIZATION
	
,,O

ClaravisNNPPERSON

andCCO

SotretNNPO

-RRB--RRB-O

meantVBDO

toTOO

preventVBO

	pregnancyNNO

inINO

womenNNSO

takingVBGO

theDTO

drugNNO
	
..OàÄÄÄ¯ˇˇˇˇ *PERSONâÄÄÄ¯ˇˇˇˇ *ORGANIZATIONﬁ

ButCCO

	voluntaryJJO

programsNNSO

likeINO

thisDTO
	
,,O

whichWDTO

haveVBPO

existedVBNO

sinceINO

theDTO

drugNNO

becameVBDO

	availableJJO

inINO

1982CDO
	
,,O

wereVBDO

notRBO

entirelyRBO


successfulJJO
	
..Oƒ

TwoCDO

toTOO

threeCDO

outINO

ofINO

1,000CDO

womenNNSO

takingVBGO

isotretinoinNNO

stillRBO

becameVBDO

pregnantJJO
	
,,O


aDTO

surveyNNO

ofINO

nearlyRBO

450,000CDO

patientsNNSO
	
,,O

	conductedVBNO

atINO

BostonNNPORGANIZATION


UniversityNNPORGANIZATION

fromINO

1989CDO

toTOO

2003CDO
	
,,O

foundVBDO
	
..OEäÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f80000000000748bf *ORGANIZATIONŒ

SoRBO
	
,,O

asINO

ofINO

theDTO

	beginningNNO

ofINO

thisDTO

yearNNO
	
,,O

theDTO

	companiesNNSO

thatWDTO

makeVBPO

isotretinoinNNO
	
,,O

togetherRBO

withINO

theDTO

FoodNNPORGANIZATION

andCCORGANIZATION

DrugNNPORGANIZATION
#
AdministrationNNPORGANIZATION
	
,,O

haveVBPO

imposedVBNO

	mandatoryJJO

prescribingNNO

rulesNNSO
	
..OEãÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f8000000000018a7c *ORGANIZATIONÓ

AnyDTO

womanNNO

ofINO

childbearingVBGO

ageNNO

whoWPO

isVBZO

givenVBNO

theDTO

drugNNO

mustMDO

meetVBO

severalJJO

requirementsNNSO
	
..Oˇ

BeforeINO

startingVBGO

theDTO


medicationNNO

shePRPO

mustMDO

haveVBO

negativeJJO

	pregnancyNNO

testsVBZO

twoCDO

monthsNNSO

inINO


aDTO

rowNNO
	
..O¡

WhileINO

takingVBGO

itPRPO
	
,,O

shePRPO

mustMDO

eitherRBO

promiseVBO

inINO

writingVBGO

toTOO

abstainVBO

fromINO

sexNNO

withINO


aDTO

manNNO

orCCO

elseJJO

useNNO

twoCDO

formsNNSO

ofINO

contraceptionNNO
	
,,O

oneCDO

ofINO

whichWDTO

mustMDO

beVBO


aDTO

highlyRBO

	effectiveJJO

kindNNO

likeINO

birthNNO

controlNNO

pillsNNSO

orCCO

theDTO


injectableJJO
!
Depo-ProveraNNPORGANIZATION
	
..OåÄÄÄ¯ˇˇˇˇ) )*ORGANIZATIONî

EachDTO

monthNNO

duringINO

herPRP$O

	treatmentNNO

-LRB--LRB-O

usuallyRBO

fiveCDO

monthsNNSO

-RRB--RRB-O

shePRPO

mustMDO

takeVBO


aDTO

	pregnancyNNO

testNNO
	
..Oò

AndCCO

shePRPO

mustMDO

documentVBO

everyDTO

stepNNO

shePRPO

takesVBZO

byINO

loggingVBGO

ontoINO

iPledgeNNO
	
,,O


aDTO

nationalJJO

onlineJJO

databaseNNO
	
..OÚ

TheDTO

newJJO

rulesNNSO

areVBPO

meantVBNO

toTOO

preventVBO

isotretinoin-relatedJJO

birthNNO

defectsNNSO

onceRBO

andCCO

forINO

allDTO
	
..O˘

ButCCO

theDTO

rulesNNSO

areVBPO

soRBO

strictJJO
	
,,O

someDTO

doctorsNNSO

sayVBPO
	
,,O

theyPRPO

mightMDO


discourageVBO

orCCO

evenRBO

preventVBO

manyJJO

patientsNNSO

fromINO

usingVBGO

theDTO

drugNNO
	
,,O

theDTO

onlyJJO

	treatmentNNO

thatWDTO

canMDO

eraseVBO

severeJJO

acneNNO
	
..O£

ManyJJO

dermatologistsNNSO

sayVBPO

theDTO

iPledgeNNO

programNNO

isVBZO

overkillJJO
	
..O

''''O‰

ItPRPO

'sVBZO

oneCDO

ofINO

theDTO

worstJJSO

thingsNNSO

thatWDTO

'sVBZO

happenedVBNO

toTOO

ourPRP$O

	specialtyNNO
	
,,O

''''O

saidVBDO

Dr.NNPPERSON

RanellaNNPPERSON

HirschNNPPERSON
	
,,O


aDTO

BostonNNPLOCATION

dermatologistNNO

whoWPO

isVBZO

theDTO

viceNNO

	presidentNNO

ofINO

theDTO

AmericanNNPORGANIZATION

SocietyNNPORGANIZATION

ofINORGANIZATION

CosmeticNNPORGANIZATION
 
DermatologyNNPORGANIZATION

&CCORGANIZATION

	AestheticNNPORGANIZATION

SurgeryNNPORGANIZATION
	
..O

''''OçÄÄÄ¯ˇˇˇˇ %*ORGANIZATIONAéÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f800000000000af9f *LOCATIONèÄÄÄ¯ˇˇˇˇ *PERSONÀ

WePRPO

'reVBPO

takingVBGO


aDTO

veryRBO

goodJJO

drugNNO

thatWDTO

isVBZO

forINO

manyJJO

peopleNNSO

theDTO

onlyRBO

realJJO

choiceNNO

outINO

ofINO


reasonableJJO

accessNNO
	
..O

''''Oﬁ

AcneNNPO

isVBZO

theDTO

mostRBSO

commonJJO

skinNNO

diseaseNNO

inINO

theDTO

UnitedNNPLOCATION

StatesNNPSLOCATION
	
,,O

	affectingVBGO

asINO

manyJJO

asINO

85CDO

percentNNO

ofINO

peopleNNSO

fromINO

12CDO

toTOO

24CDO

yearsNNSO

oldJJO
	
,,O

	accordingVBGO

toTOO

theDTO

NationalNNPORGANIZATION
 

InstitutesNNPSORGANIZATION

ofINORGANIZATION

HealthNNPORGANIZATION
	
..OEêÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f800000000005bf54 !*ORGANIZATIONAëÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f80000000045917bf	 
*LOCATION¿

NearlyRBO

17CDO

millionCDO

peopleNNSO

haveVBPO

itPRPO
	
,,O

mostJJSO

ofINO

themPRPO

underINO

30CDO
	
..OÇ

ManyJJO

acneNNO

	sufferersNNSO

areVBPO

	satisfiedVBNO

withINO

simpleJJO
	
,,O

over-the-counterJJO


treatmentsNNSO

likeINO

benzoylNNO

peroxideNNO

creamNNO
	
..O≠

ButCCO

isotretinoinNNO

hasVBZO

beenVBNO

theDTO


undisputedJJO

goldJJO

standardNNO

forINO

extremeJJO

casesNNSO
	
,,O

andCCO

evenRBO

forINO

manyJJO

moderateJJO

onesNNSO
	
..O§

-LRB--LRB-O

TheDTO

F.D.A.NNPORGANIZATION

hasVBZO

approvedVBNO

theDTO

drugNNO

onlyRBO

forINO

severeJJO

acneNNO
	
,,O

butCCO

doctorsNNSO

mayMDO

useVBO

itPRPO

	off-labelJJO

toTOO

treatVBO

milderNNO

problemsNNSO
	
..O

-RRB--RRB-OíÄÄÄ¯ˇˇˇˇ *ORGANIZATIONé

RocheNNPPERSON
	
,,O

theDTO

makerNNO

ofINO

AccutaneNNPORGANIZATION
	
,,O

	estimatesVBZO

thatINO

nearlyRBO

sevenCDO

millionCDO

	AmericansNNPSO

haveVBPO

takenVBNO

itsPRP$O

drugNNO
	
..OìÄÄÄ¯ˇˇˇˇ *ORGANIZATION?îÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f8000000000c70933   *PERSON÷

HundredsNNSO

ofINO

	thousandsNNSO

moreJJRO

haveVBPO

takenVBNO

otherJJO

brandsNNSO

ofINO

isotretinoinNNO

sinceINO

theyPRPO

cameVBDO

onINO

theDTO

marketNNO

afterINO

RocheNNPPERSON

'sPOSO

patentNNO

expiredVBDO

inINO

2002CDO
	
..O

''''O?ïÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f8000000000c70933 *PERSON˜

ItPRPO

isVBZO

perhapsRBO

theDTO

mostRBSO

revolutionaryJJO

drugNNO

inINO

dermatologyNNO

everRBO
	
,,O

''''O

saidVBDO

Dr.NNPPERSON

LeeNNPPERSON

ZaneNNPPERSON
	
,,O

theDTO

directorNNO

ofINO

theDTO

AcneNNPO

	SpecialtyNNPO

PracticeNNPO

atINO

theDTO


UniversityNNPORGANIZATION

ofINORGANIZATION


CaliforniaNNPORGANIZATION
	
,,O

SanNNPLOCATION

	FranciscoNNPLOCATION
	
..O

''''OAñÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f8000000000061a55 *LOCATIONEóÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f800000000003e9cc *ORGANIZATIONòÄÄÄ¯ˇˇˇˇ *PERSON‹

TheDTO

numberNNO

ofINO

peopleNNSO

walkingVBGO

aroundINO

withINO

reallyRBO

severeJJO

scarringNNO

acneNNO

hasVBZO


diminishedVBNO

significantlyRBO

withINO

theDTO

adventNNO

ofINO

isotretinoinNNO
	
..O

''''Oú

TheDTO

mostRBSO

commonlyRBO

reportedVBNO

sideNNO

effectsNNSO

areVBPO

dryJJO

skinNNO

andCCO

chappedVBDO

lipsNNSO
	
,,O

butCCO

theDTO

drugNNO

hasVBZO

alsoRBO

beenVBNO

linkedVBNO

toTOO

fatigueNNO
	
,,O

severeJJO

jointJJO

painNNO
	
,,O

headacheNNO
	
,,O

upsetJJO

stomachNNO

andCCO

blurredVBDO

visionNNO
	
..O‡

SomeDTO

suspectVBPO

thatINO

isotretinoinNNO

mayMDO

alsoRBO

causeVBO


depressionNNO

orCCO

evenRBO

suicideNNO
	
,,O

althoughINO


scientificJJO

studiesNNSO

haveVBPO

notRBO

demonstratedVBNO


aDTO


connectionNNO
	
..Oï

ButCCO

theDTO


importanceNNO

ofINO

avoidingVBGO

	pregnancyNNO

isVBZO


undisputedVBNO
	
..O›

IsotretinoinNNPO

causesVBZO

theDTO

mostRBSO

severeJJO

birthNNO

defectsNNSO

ifINO

anDTO

	expectantJJO

motherNNO

takesVBZO

itPRPO

duringINO

herPRP$O

firstJJO

	trimesterNNO
	
,,O

whenWRBO

shePRPO

isVBZO

leastRBSO

likelyJJO

toTOO

knowVBO

shePRPO

isVBZO

pregnantJJO
	
..O

''''OÓ

ThereEXO

'sVBZO

	somethingNNO

thatWDTO

'sVBZO

knownVBNO

asINO

AccutaneNNPO

embryopathyNNO
	
,,O

''''O

saidVBDO

MargaretNNPPERSON

HoneinNNPPERSON
	
,,O

anDTO

epidemiologistNNO

atINO

theDTO

NationalNNPORGANIZATION

CenterNNPORGANIZATION

onINORGANIZATION

BirthNNPORGANIZATION

DefectsNNSORGANIZATION

andCCORGANIZATION
"
DevelopmentalNNPORGANIZATION
"
DisabilitiesNNPSORGANIZATION
	
..OôÄÄÄ¯ˇˇˇˇ *ORGANIZATIONöÄÄÄ¯ˇˇˇˇ *PERSON´

ExposedVBNO

fetusesNNSO
	
,,O

shePRPO

saidVBDO
	
,,O

''''O

oftenRBO

haveVBPO


aDTO

patternNNO

ofINO

severalJJO

majorJJO

malformationsNNSO
	
,,O

''''O

	includingVBGO

thoseDTO

ofINO

theDTO

headNNO
	
,,O

earsNNSO
	
,,O

eyesNNSO
	
,,O

faceNNO

andCCO

heartNNO
	
,,O

asRBO

wellRBO

asINO

brainNNO

abnormalitiesNNSO
	
..O∑

YetRBO

someDTO

doctorsNNSO

sayVBPO

thatINO

rareJJO

pregnanciesNNSO

shouldMDO

notRBO

limitVBO

drugNNO

accessNNO

forINO

theDTO

millionsNNSO

whoWPO

getVBPO

acneNNO
	
..O

''''Où

IfINO

theDTO

useNNO

ofINO

AccutaneNNPO

goesVBZO

downINO

75CDO

percentNNO
	
,,O

inINO

myPRP$O

mindNNO
	
,,O

theDTO

programNNO

willMDO

beVBO


aDTO

failureNNO
	
,,O

becauseINO

thereEXO

willMDO

beVBO

tensNNSO

ofINO

	thousandsNNSO

ofINO

peopleNNSO

whoWPO

willMDO

haveVBO

beenVBNO

hurtVBNO
	
,,O

''''O

saidVBDO

Dr.NNPPERSON

NoahNNPPERSON


ScheinfeldNNPPERSON
	
,,O


aDTO

dermatologistNNO

atINO

St.NNPLOCATION

LukeNNPLOCATION

'sPOSO
	
-:O

	RooseveltNNPORGANIZATION

HospitalNNPORGANIZATION

CenterNNPORGANIZATION

inINO

	ManhattanNNPLOCATION
	
..OAõÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f800000000005aca65 5*LOCATIONúÄÄÄ¯ˇˇˇˇ1 3*ORGANIZATIONùÄÄÄ¯ˇˇˇˇ- .*LOCATIONûÄÄÄ¯ˇˇˇˇ& (*PERSONË

Dr.NNPPERSON


ScheinfeldNNPPERSON

	advocatesVBZO

	returningVBGO

toTOO


aDTO

	voluntaryJJO

pregnancy-preventionNNO

programNNO
	
..O

''''OüÄÄÄ¯ˇˇˇˇ  *PERSON˙

IPRPO

wouldMDO

haveVBO

patientsNNSO

certifyRBO

onINO


aDTO

writtenVBNO

	statementNNO

atINO

eachDTO

visitNNO

thatINO

theyPRPO

areVBPO

notRBO

sharingVBGO

pillsNNSO
	
,,O

knowVBPO

theDTO

risksNNSO

andCCO

areVBPO

usingVBGO

birthNNO

controlNNO

pillsNNSO
	
,,O

''''O

hePRPO

saidVBDO
	
..O˜

Dr.NNPPERSON

SidneyNNPPERSON

M.NNPPERSON

WolfeNNPPERSON
	
,,O

theDTO

directorNNO

ofINO

PublicNNPORGANIZATION

CitizenNNPORGANIZATION

'sPOSORGANIZATION

HealthNNPORGANIZATION

ResearchNNPORGANIZATION

GroupNNPORGANIZATION
	
,,O


aDTO

consumerNNO

advocacyNNO

organizationNNO
	
,,O

arguedVBDO

thatINO

doctorsNNSO

haveVBPO

overprescribedVBNO

isotretinoinINO

toTOO

peopleNNSO

whoseWP$O

acneNNO

isVBZO

notRBO

severeJJO

enoughRBO

toTOO

needVBO

itPRPO
	
..O†ÄÄÄ¯ˇˇˇˇ *ORGANIZATION°ÄÄÄ¯ˇˇˇˇ  *PERSONƒ

StrengtheningVBGO

	voluntaryJJO

precautionsNNSO
	
,,O

hePRPO

addedVBDO
	
,,O

hasVBZO

doneVBNO

nothingNNO

toTOO

reduceVBO

pregnanciesNNSO

inINO

womenNNSO

takingVBGO

theDTO

drugNNO
	
..O

''''Oõ

TheDTO

onlyJJO

alternativeNNO

isVBZO

reallyRBO

toTOO

haveVBO

someDTO

imposedJJO

restrictionNNO
	
,,O

''''O

Dr.NNPPERSON

WolfeNNPPERSON

saidVBDO
	
..O¢ÄÄÄ¯ˇˇˇˇ *PERSON»

Dr.NNPPERSON

NancyNNPPERSON

GreenNNPPERSON
	
,,O

theDTO

medicalJJO

directorNNO

ofINO

theDTO

MarchNNPO

ofINO

DimesNNPO
	
,,O

whichWDTO

supportsVBZO

researchNNO

andCCO

	educationNNO

toTOO

preventVBO

birthNNO

defectsNNSO
	
,,O

saidVBDO
	
::O

''''O

WePRPO

'veVBPO

beenVBNO


advocatingVBGO

sinceINO

2000CDO

forINO

F.D.A.NNPORGANIZATION

toTOO

takeVBO

thisDTO

kindNNO

ofINO

stepNNO
	
..O£ÄÄÄ¯ˇˇˇˇ! !*ORGANIZATION§ÄÄÄ¯ˇˇˇˇ  *PERSON[

IsVBZO

thisDTO

theDTO

perfectJJO

solutionNNO
	
?.On

WePRPO

'llMDO

haveVBO

toTOO

waitVBO

andCCO

seeVBO
	
..O—

WePRPO

areVBPO


cautiouslyRBO


optimisticJJO

thatINO

thisDTO

isVBZO

theDTO

rightJJO

wayNNO

toTOO

goVBO
	
..O

''''O¡

TheDTO

newJJO

rulesNNSO

requireVBPO

thatINO

menNNSO

whoWPO

areVBPO


prescribedVBNO

isotretinoinRBO
	
,,O

asRBO

wellRBO

asINO

womenNNSO

whoWPO

haveVBPO

hadVBNO

hysterectomiesNNSO

orCCO

areVBPO

	otherwiseRBO

unableJJO

toTOO

becomeVBO

pregnantJJO
	
,,O

registerNNO

withINO

iPledgeNNO
	
,,O

thoughINO

theyPRPO

areVBPO

notRBO

requiredVBNO

toTOO

useVBO

contraceptionNNO

orCCO

haveVBO

	pregnancyNNO

testsNNSO
	
..O¸

AsINO

ofINO

MarchNNPO


1CDO


physiciansNNSO

andCCO

pharmacistsNNSO

willMDO

alsoRBO

beVBO

requiredVBNO

toTOO

registerVBO

eachDTO

isotretinoinNNO

prescriptionNNO

withINO

iPledgeNNO

toTOO

verifyVBO

thatINO

theyPRPO

haveVBPO

doneVBNO

theirPRP$O

partNNO

toTOO

ensureVBO

againstINO

	pregnancyNNO
	
..O“

DoctorsNNSO

sayVBPO

theDTO

newJJO

rulesNNSO

mayMDO

forceVBO

themPRPO

toTOO

raiseVBO

theDTO

priceNNO

ofINO

	treatmentNNO

toTOO

coverVBO

theDTO

timeNNO

andCCO

testingNNO

requiredVBNO
	
..Oè

TheDTO

drugsNNSO

aloneRBO

costVBPO

aboutINO
	
$$O

600CDO


aDTO

monthNNO
	
..OÙ

SomeDTO

doctorsNNSO

areVBPO

expectedVBNO

toTOO

avoidVBO

theDTO

troubleNNO

byINO

turningVBGO

toTOO

lessRBRO

	effectiveJJO


treatmentsNNSO
	
..Oı

Dr.NNPPERSON

RonaldNNPPERSON

G.NNPPERSON

WheelandNNPPERSON
	
,,O

theDTO

chiefNNO

ofINO

dermatologyNNO

atINO

theDTO


UniversityNNPORGANIZATION

ofINORGANIZATION

ArizonaNNPORGANIZATION

HealthNNPORGANIZATION

SciencesNNPSORGANIZATION

CenterNNPORGANIZATION

inINO

TucsonNNPLOCATION
	
,,O

saidVBDO

itPRPO

isVBZO

''''O

almostRBO


inevitableJJO

''''O

thatINO

isotretinoinNNO

willMDO

beVBO


prescribedVBNO

mainlyRBO

inINO

academicJJO

medicalJJO

centersNNSO

inINO

majorJJO

citiesNNSO

andCCO

inINO

	practicesNNSO

thatWDTO


specializeVBPO

inINO

acneJJO

	treatmentNNO
	
..OA•ÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f800000000006dc19 *LOCATION¶ÄÄÄ¯ˇˇˇˇ *ORGANIZATIONßÄÄÄ¯ˇˇˇˇ  *PERSONê

HePRPO

saidVBDO

hePRPO

isVBZO

''''O

fearfulJJO

thatINO


aDTO

lotNNO

ofINO

legislatorsNNSO

doVBPO

n'tRBO


understandVBO

theDTO

severityNNO

ofINO

thisDTO

devastatingJJO
	
,,O

scarringJJO
	
,,O

horribleJJO

diseaseNNO
	
..O

''''Oé

TheDTO

iPledgeNNO

rulesNNSO

areVBPO


comparableJJO

toTOO

thoseDTO

thatWDTO

applyVBPO

toTOO

thalidomideVBO
	
,,O

theDTO

medicineNNO

onceRBO

usedVBDO

toTOO

treatVBO

morningNNO

sicknessNNO

thatWDTO

becameVBDO

knownVBNO

inINO

theDTO

1960CDO

'sPOSO

forINO

causingVBGO

severeJJO

birthNNO

defectsNNSO
	
..O¿

ThalidomideNNPO
	
,,O

nowRBO

usedVBNO

toTOO

treatVBO

bloodNNO

cancerNNO
	
,,O

canMDO

beVBO


prescribedVBNO

toTOO

womenNNSO

onlyRBO

ifINO

theyPRPO

promiseVBPO

eitherCCO

toTOO

avoidVBO

sexNNO

orCCO

toTOO

useVBO

twoCDO

formsNNSO

ofINO

birthNNO

controlNNO
	
,,O

andCCO

toTOO

haveVBO

regularJJO

	pregnancyNNO

testsNNSO
	
..O°

ButCCO

doctorsNNSO

sayVBPO

thatINO

becauseINO

acneNNO

isVBZO

soRBO


widespreadJJO
	
,,O

theDTO

restrictionsNNSO

onINO

isotretinoinNNO

areVBPO

moreRBRO

onerousJJO
	
..O“

Dr.NNPPERSON

ZaneNNPPERSON
	
,,O

ofINO

theDTO


UniversityNNPORGANIZATION

ofINORGANIZATION


CaliforniaNNPORGANIZATION
	
,,O

saidVBDO

someDTO

patientsNNSO

mayMDO

beVBO


encouragedVBNO

toTOO

seekVBO

theDTO

drugNNO

fromINO

foreignJJO

sourcesNNSO
	
,,O

forgoingVBGO

supervisionNNO

byINO


aDTO

	physicianNNO

andCCO

anyDTO

	educationNNO

aboutINO

theDTO

risksNNSO

ofINO

	pregnancyNNO
	
..OE®ÄÄÄ¯ˇˇˇˇ&/guid/9202a8c04000641f800000000003e9cc *ORGANIZATION©ÄÄÄ¯ˇˇˇˇ  *PERSON•

MostRBSO

	troublingJJO

toTOO

dermatologistsNNSO

isVBZO

theDTO

possibilityNNO

thatINO


aDTO

fewJJO

pregnanciesNNSO

mayMDO

stillRBO

occurVBO
	
,,O

causingVBGO

theDTO

F.D.A.NNPORGANIZATION

toTOO

banVBO

isotretinoinNNO


altogetherRBO
	
..O™ÄÄÄ¯ˇˇˇˇ *ORGANIZATIONΩ

ThisDTO
	
,,O

Dr.NNPPERSON

ZaneNNPPERSON

saidVBDO
	
,,O

''''O

willMDO

sendVBO

usPRPO

backRBO

essentiallyRBO

toTOO

theDTO

darkJJO

agesNNSO

ofINO

acneJJO

	treatmentNNO
	
,,O

whereWRBO

thereEXO

willMDO

beVBO

manyJJO
	
,,O

manyJJO
	
,,O

manyJJO

peopleNNSO

walkingVBGO

aroundINO

withINO

severeJJO
	
,,O

scarringVBGO
	
,,O

debilitatingVBGO

andCCO
$
psychologically-devastatingJJO

acneNNO
	
..O

''''O´ÄÄÄ¯ˇˇˇˇ *PERSON

SkinNNPO

DeepNNO